Perspectives and Emotional Experiences of Patients With Chronic Myeloid Leukemia During ENESTPath Clinical Trial and Treatment-Free Remission: Rationale and Protocol of the Italian Substudy

Achievement of deep molecular response following treatment with a tyrosine kinase inhibitor (TKI) allows for treatment-free remission (TFR) in many patients with chronic myeloid leukemia (CML). Successful TFR is defined as the achievement of a sustained molecular response after cessation of ongoing...

Descripción completa

Detalles Bibliográficos
Autores principales: Borghi, Lidia, Rosti, Gianantonio, Maggi, Alessandro, Breccia, Massimo, Di Bona, Eros, Iurlo, Alessandra, La Barba, Gaetano, Sportoletti, Paolo, Albano, Francesco, Galimberti, Sara, Rivellini, Flavia, Cambrin, Giovanna Rege, Capodanno, Isabella, Cuneo, Antonio, Bonifacio, Massimiliano, Sica, Simona, Arcaini, Luca, Capochiani, Enrico, Minotto, Claudia, Ciceri, Fabio, Crugnola, Monica, Di Caprio, Luigi, Supekar, Sharon, Elena, Chiara, Baccarani, Michele, Vegni, Elena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8189147/
https://www.ncbi.nlm.nih.gov/pubmed/34123791
http://dx.doi.org/10.3389/fonc.2021.638689

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8189147/
https://www.ncbi.nlm.nih.gov/pubmed/34123791
http://dx.doi.org/10.3389/fonc.2021.638689

Ejemplares similares